Literature DB >> 20060169

On the bioreactivity of triorganotin aminobenzoates. Investigation of trialkyl and triarylyltin(IV) esters of 3-amino and 4-aminobenzoic acids.

Demetrios Tzimopoulos1, Ioannis Sanidas, Anastasia-C Varvogli, Agnieszka Czapik, Maria Gdaniec, Eleni Nikolakaki, Pericles D Akrivos.   

Abstract

The synthesis and study of trimethyl-, tributyl- and triphenyltin esters of the 3- and 4-aminobenzoic acids are reported. The triorganotin derivatives are characterized by elemental analyses, FT-IR and solution (1)H and (13)C NMR spectra. The structure of the trimethyltin 4-aminobenzoate is solved by X-ray diffraction and proves to be polymeric in nature with bridging carboxylates and trigonal bipyramidal tin(IV) environment. However, all the compounds become monomeric in solution with a tetrahedral tin coordination environment in chloroform and trigonal bipyramidal in DMSO due to coordination of the solvent as the NMR spectra have revealed. The compounds exhibit variable cytotoxic activity when tested against Kappa562 myelogenous leukaemia, HeLa cervical cancer and HepG2 hepatocellular carcinoma cell lines, with the butyl derivatives being the more effective and the methyl ones the less. Interestingly, their antibacterial action was significantly lower when tested against Escherichia coli, while not appreciable direct interaction with DNA has been observed. The above observations account for a mode of action that may be related to their potential interaction with cell membranes and the subsequent inhibition of various signaling processes. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20060169     DOI: 10.1016/j.jinorgbio.2009.12.006

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  1 in total

1.  Synthesis, Characterization, Biological Activity and Molecular Docking Studies of Novel Organotin(IV) Carboxylates.

Authors:  Niaz Muhammad; Mukhtar Ahmad; Muhammad Sirajuddin; Zafar Ali; Nikolay Tumanov; Johan Wouters; Abdelbasset Chafik; Kübra Solak; Ahmet Mavi; Shabbir Muhammad; Shaukat Shujah; Saqib Ali; Abdullah G Al-Sehemi
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.